ID   MAP6_RAT                Reviewed;         952 AA.
AC   Q63560; O88748; Q6AYX8;
DT   22-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 126.
DE   RecName: Full=Microtubule-associated protein 6;
DE            Short=MAP-6;
DE   AltName: Full=145-kDa STOP;
DE            Short=STOP145;
DE   AltName: Full=Stable tubule-only polypeptide;
DE            Short=STOP;
GN   Name=Map6; Synonyms=Mtap6;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, FUNCTION,
RP   INTERACTION WITH CALMODULIN, AND SUBCELLULAR LOCATION.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=8700896; DOI=10.1073/pnas.93.5.2125;
RA   Bosc C., Cronk J.D., Pirollet F., Watterson D.M., Haiech J., Job D.,
RA   Margolis R.L.;
RT   "Cloning, expression, and properties of the microtubule-stabilizing protein
RT   STOP.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:2125-2130(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, SUBCELLULAR LOCATION, AND
RP   DEVELOPMENTAL STAGE.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=9660871; DOI=10.1083/jcb.142.1.167;
RA   Guillaud L., Bosc C., Fourest-Lieuvin A., Denarier E., Pirollet F.,
RA   Lafanechere L., Job D.;
RT   "STOP proteins are responsible for the high degree of microtubule
RT   stabilization observed in neuronal cells.";
RL   J. Cell Biol. 142:167-179(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-613 (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 33-77; 139-150; 202-226; 239-247; 285-293; 331-364;
RP   377-410; 455-462 AND 466-477, INTERACTION WITH TMEM106B, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RX   PubMed=24357581; DOI=10.1002/embj.201385857;
RA   Schwenk B.M., Lang C.M., Hogl S., Tahirovic S., Orozco D., Rentzsch K.,
RA   Lichtenthaler S.F., Hoogenraad C.C., Capell A., Haass C., Edbauer D.;
RT   "The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of
RT   lysosomes.";
RL   EMBO J. 33:450-467(2014).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=3456161; DOI=10.1073/pnas.83.3.639;
RA   Margolis R.L., Rauch C.T., Job D.;
RT   "Purification and assay of a 145-kDa protein (STOP145) with microtubule-
RT   stabilizing and motility behavior.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:639-643(1986).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH CALMODULIN.
RX   PubMed=11413126; DOI=10.1074/jbc.m011614200;
RA   Bosc C., Frank R., Denarier E., Ronjat M., Schweitzer A., Wehland J.,
RA   Job D.;
RT   "Identification of novel bifunctional calmodulin-binding and microtubule-
RT   stabilizing motifs in STOP proteins.";
RL   J. Biol. Chem. 276:30904-30913(2001).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=14724383; DOI=10.1023/b:neur.0000011334.70648.87;
RA   Slaughter T., Black M.M.;
RT   "STOP (stable-tubule-only-polypeptide) is preferentially associated with
RT   the stable domain of axonal microtubules.";
RL   J. Neurocytol. 32:399-413(2003).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-185; SER-590; SER-681;
RP   SER-736 AND SER-951, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE (ISOFORMS 1 AND 2),
RP   PALMITOYLATION AT CYS-5; CYS-10 AND CYS-11, AND MUTAGENESIS OF CYS-5 AND
RP   10-CYS-CYS-11.
RX   PubMed=28521134; DOI=10.1016/j.neuron.2017.04.042;
RA   Tortosa E., Adolfs Y., Fukata M., Pasterkamp R.J., Kapitein L.C.,
RA   Hoogenraad C.C.;
RT   "Dynamic palmitoylation targets MAP6 to the axon to promote microtubule
RT   stabilization during neuronal polarization.";
RL   Neuron 94:809-825(2017).
CC   -!- FUNCTION: Involved in microtubule stabilization in many cell types,
CC       including neuronal cells (PubMed:11413126, PubMed:28521134,
CC       PubMed:3456161, PubMed:8700896, PubMed:9660871). Specifically has
CC       microtubule cold stabilizing activity (PubMed:3456161). Involved in
CC       dendrite morphogenesis and maintenance by regulating lysosomal
CC       trafficking via its interaction with TMEM106B (By similarity).
CC       Regulates KIF5A-mediated axonal cargo transport (PubMed:28521134).
CC       Regulates axonal growth during neuron polarization (PubMed:28521134).
CC       {ECO:0000250|UniProtKB:Q96JE9, ECO:0000269|PubMed:11413126,
CC       ECO:0000269|PubMed:28521134, ECO:0000269|PubMed:3456161,
CC       ECO:0000269|PubMed:8700896, ECO:0000269|PubMed:9660871}.
CC   -!- SUBUNIT: Interacts with calmodulin (via C-terminus); the interaction is
CC       dependent on Ca(2+) (PubMed:11413126, PubMed:8700896). Interacts (via
CC       C-terminus) with TMEM106B (via N-terminus) (PubMed:24357581). Interacts
CC       with ZDHHC13 (via ANK repeats) (By similarity). Interacts with ZDHHC17
CC       (via ANK repeats) (By similarity). {ECO:0000250|UniProtKB:Q7TSJ2,
CC       ECO:0000250|UniProtKB:Q96JE9, ECO:0000269|PubMed:11413126,
CC       ECO:0000269|PubMed:24357581, ECO:0000269|PubMed:8700896}.
CC   -!- INTERACTION:
CC       Q63560; Q6AYA5: Tmem106b; NbExp=6; IntAct=EBI-1638469, EBI-9316198;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:14724383, ECO:0000269|PubMed:28521134,
CC       ECO:0000269|PubMed:3456161, ECO:0000269|PubMed:8700896,
CC       ECO:0000269|PubMed:9660871}. Golgi apparatus
CC       {ECO:0000269|PubMed:28521134}. Cell projection, axon
CC       {ECO:0000269|PubMed:28521134, ECO:0000269|PubMed:9660871}. Cell
CC       projection, dendrite {ECO:0000269|PubMed:28521134}. Cytoplasmic
CC       vesicle, secretory vesicle membrane {ECO:0000269|PubMed:28521134};
CC       Lipid-anchor {ECO:0000269|PubMed:28521134}; Cytoplasmic side
CC       {ECO:0000269|PubMed:28521134}. Note=Isoform 1 and isoform 2 associate
CC       with axonal microtubules in neuronal cells (PubMed:8700896,
CC       PubMed:9660871). Localizes predominantly in the proximal part of the
CC       axon (PubMed:28521134). Preferentially concentrated on a portion of the
CC       microtubule polymer in which tubulin is modified by detyrosination and
CC       acetylation and is also resistant to depolymerization induced by both
CC       nocodazole and cold (PubMed:14724383, PubMed:28521134, PubMed:9660871).
CC       In unpolarized neurons, localizes to the Golgi and to secretory
CC       vesicles accumulating transiently at the tips of a subset of neurites
CC       (PubMed:28521134). Following neuronal polarization and during axon
CC       outgrowth, accumulates in the axonal growth cone and subsequently
CC       localizes throughout the axon (PubMed:28521134). Partially localizes to
CC       dendrites in mature neurons (PubMed:28521134).
CC       {ECO:0000269|PubMed:14724383, ECO:0000269|PubMed:28521134,
CC       ECO:0000269|PubMed:8700896, ECO:0000269|PubMed:9660871}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=N-STOP, Neuronal STOP;
CC         IsoId=Q63560-1; Sequence=Displayed;
CC       Name=2; Synonyms=E-STOP, Early STOP;
CC         IsoId=Q63560-2; Sequence=VSP_034728, VSP_034729;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is specifically expressed in adult brain.
CC       Isoform 2 is predominantly expressed in embryonic brain; expression
CC       persists at low levels in the adult brain.
CC       {ECO:0000269|PubMed:9660871}.
CC   -!- DEVELOPMENTAL STAGE: At 17.5 dpc, expressed in brain including
CC       hippocampus and corpus callosum (PubMed:28521134). Isoform 1:
CC       Expression begins after birth at P1-P5 stages and is maintained in
CC       adults (PubMed:28521134, PubMed:9660871). Expressed in mature neurons
CC       (PubMed:28521134). Isoform 2: Expressed at 13 dpc, 16 dpc and 18 dpc
CC       stages (PubMed:28521134, PubMed:9660871). Expression is increased at
CC       P1-P5 stages and persists at low levels in the adult brain
CC       (PubMed:28521134, PubMed:9660871). Expressed in unpolarized hippocampal
CC       neurons and throughout neuronal development (PubMed:28521134).
CC       {ECO:0000269|PubMed:28521134, ECO:0000269|PubMed:9660871}.
CC   -!- PTM: Palmitoylated. Probably depalmitoylated by ABHD17A, ABHD17B and
CC       ABHD17C. During neuronal polarization, palmitoylation and
CC       depalmitoylation cycles regulate MAP6 shuttling between secretory
CC       vesicles and microtubules, and its polarized distribution in the axon.
CC       {ECO:0000269|PubMed:28521134}.
CC   -!- SIMILARITY: Belongs to the STOP family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH78848.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X93495; CAA63762.1; -; mRNA.
DR   EMBL; AJ002556; CAA05555.1; -; mRNA.
DR   EMBL; BC078848; AAH78848.1; ALT_SEQ; mRNA.
DR   RefSeq; NP_058900.1; NM_017204.1.
DR   AlphaFoldDB; Q63560; -.
DR   BioGRID; 248100; 12.
DR   IntAct; Q63560; 6.
DR   MINT; Q63560; -.
DR   STRING; 10116.ENSRNOP00000032018; -.
DR   GlyGen; Q63560; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q63560; -.
DR   PhosphoSitePlus; Q63560; -.
DR   SwissPalm; Q63560; -.
DR   jPOST; Q63560; -.
DR   PaxDb; 10116-ENSRNOP00000032018; -.
DR   UCSC; RGD:61804; rat. [Q63560-1]
DR   AGR; RGD:61804; -.
DR   RGD; 61804; Map6.
DR   eggNOG; ENOG502QS1F; Eukaryota.
DR   InParanoid; Q63560; -.
DR   OrthoDB; 4641609at2759; -.
DR   PhylomeDB; Q63560; -.
DR   PRO; PR:Q63560; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:UniProtKB.
DR   GO; GO:1904115; C:axon cytoplasm; IEA:GOC.
DR   GO; GO:0005801; C:cis-Golgi network; IBA:GO_Central.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0005798; C:Golgi-associated vesicle; IBA:GO_Central.
DR   GO; GO:0005874; C:microtubule; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0099503; C:secretory vesicle; IDA:UniProtKB.
DR   GO; GO:0030658; C:transport vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0019896; P:axonal transport of mitochondrion; IMP:UniProtKB.
DR   GO; GO:0030705; P:cytoskeleton-dependent intracellular transport; IBA:GO_Central.
DR   GO; GO:0048813; P:dendrite morphogenesis; ISS:UniProtKB.
DR   GO; GO:0032418; P:lysosome localization; ISS:UniProtKB.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro.
DR   GO; GO:0050772; P:positive regulation of axonogenesis; IMP:UniProtKB.
DR   GO; GO:0070507; P:regulation of microtubule cytoskeleton organization; IMP:UniProtKB.
DR   InterPro; IPR007882; MAP6.
DR   PANTHER; PTHR14759:SF29; MICROTUBULE-ASSOCIATED PROTEIN 6; 1.
DR   PANTHER; PTHR14759; STOP PROTEIN; 1.
DR   Pfam; PF21410; MAP6; 7.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calmodulin-binding; Cell projection; Cytoplasm;
KW   Cytoplasmic vesicle; Cytoskeleton; Direct protein sequencing;
KW   Golgi apparatus; Lipoprotein; Membrane; Microtubule; Palmitate;
KW   Phosphoprotein; Reference proteome; Repeat; Transport.
FT   CHAIN           1..952
FT                   /note="Microtubule-associated protein 6"
FT                   /id="PRO_0000344046"
FT   REPEAT          222..267
FT                   /note="Mc-1"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REPEAT          268..313
FT                   /note="Mc-2"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REPEAT          314..359
FT                   /note="Mc-3"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REPEAT          360..405
FT                   /note="Mc-4"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REPEAT          406..451
FT                   /note="Mc-5"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REGION          1..15
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REGION          37..457
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          116..139
FT                   /note="Mn 1"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REGION          124..138
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REGION          151..174
FT                   /note="Mn 2"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REGION          160..174
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REGION          187..201
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REGION          222..451
FT                   /note="5 X approximate tandem repeat Mc"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REGION          235..249
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REGION          280..294
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REGION          325..339
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REGION          373..387
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REGION          421..435
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REGION          473..496
FT                   /note="Mn 3"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REGION          481..495
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REGION          486..952
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          532..546
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   REGION          559..573
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000269|PubMed:11413126"
FT   COMPBIAS        40..56
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        150..164
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        177..191
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        413..429
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        525..548
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        590..620
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        763..779
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        897..919
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         98
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7TSJ2"
FT   MOD_RES         141
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7TSJ2"
FT   MOD_RES         185
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         207
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7TSJ2"
FT   MOD_RES         590
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         681
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         736
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         951
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   LIPID           5
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000305|PubMed:28521134"
FT   LIPID           10
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000305|PubMed:28521134"
FT   LIPID           11
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000305|PubMed:28521134"
FT   VAR_SEQ         325
FT                   /note="R -> RDTRRKAGPAWMVTRTEGHEEKPLPPAQSQTQEGGPAAGKASGADQR
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9660871"
FT                   /id="VSP_034728"
FT   VAR_SEQ         615..952
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9660871"
FT                   /id="VSP_034729"
FT   MUTAGEN         5
FT                   /note="C->G: Loss of palmitoylation. Loss of Golgi and
FT                   secretory vesicle localization; when associated with G-10
FT                   and G-11. Loss of axonal polarization; when associated with
FT                   G-10 and G-11. Increased dendrite localization without
FT                   affecting association with microtubules; when associated
FT                   with G-10 and G-11."
FT                   /evidence="ECO:0000269|PubMed:28521134"
FT   MUTAGEN         10..11
FT                   /note="CC->GG: Loss of Golgi and secretory vesicle
FT                   localization; when associated with G-5. Loss of axonal
FT                   polarization; when associated with G-5. Increased dendrite
FT                   localization without affecting association with
FT                   microtubules; when associated with G-5."
FT                   /evidence="ECO:0000269|PubMed:28521134"
SQ   SEQUENCE   952 AA;  100485 MW;  3599A5069096FA73 CRC64;
     MAWPCITRAC CIARFWNQLD KADIAVPLVF TKYSEATEHP GAPPQPPAPP QPGLAPPSRA
     VAIETQPAQG ESDAVARATG PAPGPSGDRE TAAAPGRSGL GLGAASGSTS GSGPADSVMR
     QDYRAWKVQR PEPSCRPRSE YQPSDAPFER ETQYQKDFRA WPLPRRGDHP WIPKPVQIPA
     TSQPSPPVLG MPKRRPQSQE RGPIQLSADA RDPEGAGGAG VPAAGKASGA DQRDTRRKAG
     PAWMVTRTEG HEEKPLPPAQ SQTQEGGPAA GKASGADQRD TRRKAGPAWM VTRTEGHEEK
     PLPPAQSQTQ EGGPAAGKAS GADQRDTRRK AGPAWMVTRT EGHEETPLPP AQSQTQEGGP
     AAGKASGADQ RDTRRKAGPA WMVTRTEGHE ETPLPPAQSQ TQEGGPAAGK ASGADERDTR
     RKAGPAWMVR RSEGHEQTTA AHAQGTGPEG GKGRAVADAL NRQIREEVTS TVSSSYRNEF
     RAWTDIKPVK PIKAKPQYKP PDDKMVHETS YSAQFKGEAS KPTTADNKVV DRRRIRSLYS
     EPFKESPKVE KPSVQSSKPK KTSTSQKPLR KAKDKQVASG QAAKKKTTES PSATKPDDKE
     QSKEMNNKLA EAKESRVKPT SDKNQGPVAK EPHKDQGPVA PGLPKGQGPA VQEPLKDQGP
     MVPGLPKDQA PVVPGSLKGQ SPTAPGPPKD QGAVLLGPMK DLGPVAPASV KDQDHMASEL
     LKNKDSVPLA PAKAQSPLLP EPLKNQSPVV PARAKDQSFP APAPTPLKDP GPVIPEPEKD
     GAPMVPERRK DQNASIMASL KNEAPVASES VKNQGLGGPE PAKDTGTDLK GHGSVFVAPV
     KSQGPVVPEP TKGQDPIIPA LAKDQGPILP EPPKNQGPPV VLGPIKNQDP VIPVPLKGQD
     PVVPAPTKDP GPTAPDPLKS QGPRGPQLPT VSPSPPVMIP TVPHAEYIEG SP
//
